Sunday 4th November:
Deborah Kahn introduces open access and BioMed Central. Notes that
open access is about different business
models but the same quality & standards. The business model doesn’t
effect the peer review process. Growth has been fast since 2000. Although biomedicine
leads, growing in all areas – including in the social sciences.
OA has a number of distinct advantages Deborah says - OA journals are not
limited by size like a paper journal is and thus publish inclusively. If the science is good a paper gets in, rather than an editor asking ‘is this going to be a headline paper?’. Papers also get read widely much more quickly - within a
few weeks of publishing several titles got 12,000 accesses.
The second presentation is from Eve Gray